| Literature DB >> 32847641 |
Sarimer M Sánchez1,2, Eileen F Searle3,4, David Rubins5,6, Sayon Dutta6,7,8, Winston Ware9, Paul D Biddinger3,4,7,8, Erica S Shenoy1,2,4,7.
Abstract
The early phase of the coronavirus disease 2019 (COVID-19) pandemic and ongoing efforts for mitigation underscore the importance of universal travel and symptom screening. We analyzed adherence to documentation of travel and symptom screening through a travel navigator tool with clinical decision support to identify patients at risk for Middle East Respiratory Syndrome.Entities:
Mesh:
Year: 2020 PMID: 32847641 DOI: 10.1017/ice.2020.338
Source DB: PubMed Journal: Infect Control Hosp Epidemiol ISSN: 0899-823X Impact factor: 3.254